Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001641172-25-020075
Filing Date
2025-07-17
Accepted
2025-07-17 16:59:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5882
  Complete submission text file 0001641172-25-020075.txt   7567
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Subject) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-94258 | Film No.: 251131309
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address SPERLRING 2 PFAFFENHOFEN 2M 85276
Business Address SPERLRING 2 PFAFFENHOFEN 2M 85276 498441 78644 14
Orca Capital AG (Filed by) CIK: 0002052389 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SCHEDULE 13G/A